WARRANT TO PURCHASE STOCK

EXHIBIT 10.21

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO RULE 144 OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

WARRANT TO PURCHASE STOCK

THIS WARRANT TO PURCHASE STOCK (“WARRANT”) CERTIFIES THAT, for good and valuable consideration, the receipt of which is hereby acknowledged, COMERICA BANK, a Michigan banking corporation, or its assignee (“Holder”), is entitled to purchase the number of fully paid and nonassessable shares of the class of securities (the “Shares”) of NEXSAN CORPORATION (the “Company”) at the initial exercise price per Share (the “Warrant Price”) all as set forth above and as adjusted pursuant to this Warrant, subject to the provisions and upon the terms and conditions set forth in this Warrant.

ARTICLE 1
EXERCISE

1.1           Method of Exercise.  Holder may exercise this Warrant by delivering this Warrant and a duly executed Notice of Exercise in substantially the form attached as Appendix 1 to the principal office of the Company.  Holder shall also deliver to the Company a check or wire for the aggregate Warrant Price for the Shares being purchased.

1.2           Delivery of Certificate and New Warrant.  Within 45 days after Holder exercises this Warrant, the Company shall deliver to Holder certificates for the Shares acquired and, if this Warrant has not been fully exercised and has not expired, a new warrant representing the Shares not so acquired.

1.3           Replacement of Warrants.  In the case of loss, theft or destruction of this Warrant, on delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company or, in the case of mutilation, on surrender and cancellation of this Warrant, the

Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor.

1.4           Acquisition of the Company.

1.4.1        “Acquisition.”  For the purpose of this Warrant, “Acquisition” means (a) any sale, license, or other disposition of all or substantially all of the assets (including intellectual property) of the Company, or (b) any reorganization, consolidation, merger or sale of the voting securities of the Company or any other transaction where the holders of the Company’s securities before the transaction beneficially own less than 50% of the outstanding voting securities of the surviving entity after the transaction.

1.4.2        Assumption of Warrant.  Upon the closing of any Acquisition (other than an Acquisition in which the consideration received by the Company’s stockholders consists solely of cash), and as a condition precedent thereto, the successor or surviving entity shall assume the obligations of this Warrant, and this Warrant shall be exercisable for the same securities, cash, and property as would be payable for the Shares issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on the record date for the Acquisition and subsequent closing.  The Warrant Price shall be adjusted accordingly, and the Warrant Price and number and class of Shares shall continue to be subject to adjustment from time to time in accordance with the provisions hereof.

ARTICLE 2
ADJUSTMENTS TO THE SHARES

2.1           Stock Dividends, Splits, Etc.  If the Company declares or pays a dividend on its common stock payable in common stock, or other securities, or subdivides the outstanding common stock into a greater amount of common stock, then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without cost to Holder, the total number and kind of securities to which Holder would have been entitled had Holder owned the Shares of record as of the date the dividend or subdivision occurred.

2.2           Reclassification, Exchange or Substitution.  Upon any reclassification, exchange, substitution, or other event that results in a change of the number and/or class of the securities issuable upon exercise or conversion of this Warrant, Holder shall be entitled to receive, upon exercise or conversion of this Warrant, the number and kind of securities and property that Holder would have received for the Shares if this Warrant had been exercised immediately before such reclassification, exchange, substitution, or other event.  Such an event shall include any automatic conversion of the outstanding or issuable securities of the Company of the same class or series as the Shares to common stock pursuant to the terms of the Company’s Certificate of Incorporation upon the closing of a registered public offering of the Company’s common stock.  The Company or its successor shall promptly issue to Holder a new warrant for such new securities or other property.  The new warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Article 2 including, without limitation, adjustments to the Warrant Price and to the number of securities or

2

property issuable upon exercise of the new warrant.  The provisions of this Section 2.2 shall similarly apply to successive reclassifications, exchanges, substitutions, or other events.

2.3           Adjustments for Combinations, Etc.  If the outstanding Shares are combined or consolidated, by reclassification, reverse split or otherwise, into a lesser Number of Shares, the Warrant Price shall be proportionately increased.  If the outstanding Shares are split or multiplied, by reclassification or otherwise, into a greater Number of Shares, the Warrant Price shall be proportionately decreased.

2.4           Adjustments for Diluting Issuances.  The Warrant Price and the Number of Shares issuable upon exercise of this Warrant shall be subject to adjustment, from time to time, in the manner set forth on Exhibit A, if attached, in the event of Diluting Issuances (as defined on Exhibit A).

2.5           No Impairment.  The Company shall not, by amendment of its Certificate of Incorporation or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by the Company, but shall at all times in good faith assist in carrying out all the provisions of this Article 2 and in taking all such action as may be necessary or appropriate to protect Holder’s rights under this Article 2 against impairment.

2.6           Certificate as to Adjustments.  Upon each adjustment of the Warrant Price, the Company at its expense shall promptly compute such adjustment, and furnish Holder with a certificate signed by its Chief Financial Officer setting forth such adjustment and the facts upon which such adjustment is based.  The Company shall, upon written request, furnish Holder a certificate setting forth the Warrant Price in effect upon the date thereof and the series of adjustments leading to such Warrant Price.

2.7           Fractional Shares.  No fractional Shares shall be issuable upon exercise of this Warrant and the Number of Shares to be issued shall be rounded down to the nearest whole Share.  If a fractional share interest arises upon any exercise of the Warrant, the Company shall eliminate such fractional share interest by paying Holder an amount computed by multiplying the fractional interest by the fair market value, as determined by the Company’s Board of Directors, of a full Share.

ARTICLE 3
REPRESENTATIONS AND COVENANTS OF THE COMPANY

3.1           Representations and Warranties.  The Company hereby represents and warrants to, and agrees with, the Holder as follows;

3.1.1        The initial Warrant Price referenced on the first page of this Warrant is not greater than the fair market value of the Shares as of the date of this Warrant.

3.1.2        All Shares which may be issued upon the exercise of the purchase right represented by this Warrant, and all securities, if any, issuable upon conversion of the Shares, shall, upon issuance, be duly authorized, validly issued, fully paid and

3

nonassessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal and state securities laws.

3.1.3        The Company’s capitalization table attached to this Warrant is true and complete as of the Issue Date.

3.2           Notice of Certain Events.  If the Company proposes at any time (a) to declare any dividend or distribution upon its stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to offer for subscription pro rata to the holders of any class or series of its stock any additional shares of stock of any class or series or other rights; (c) to effect any reclassification or recapitalization of stock; or (d) to merge or consolidate with or into any other corporation, or sell, lease, license, or convey all or substantially all of its assets, or to liquidate, dissolve or wind up, then, in connection with each such event, the Company shall give Holder (1) at least 10 days prior written notice of the date on which a record will be taken for such dividend, distribution, or subscription rights and specifying the date on which the holders of stock will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (a) and (b) above; and (2) in the case of the matters referred to in (c) and (d) above at least 10 days prior written notice of the date when the same will take place (and specifying the date on which the holders of stock will be entitled to exchange their stock for securities or other property deliverable upon the occurrence of such event).

3.3           Information Rights.  So long as the Holder holds this Warrant and/or any of the Shares, the Company shall deliver to the Holder (a) promptly after mailing, copies of all communiqués to the shareholders of the Company, (b) within one hundred twenty (120) days after the end of each fiscal year of the Company, the annual audited financial statements of the Company certified by independent public accountants of recognized standing and (c) within forty-five (45) days after the end of each of the first three quarters of each fiscal year, the Company’s quarterly, unaudited financial statements.

3.4           Registration Under Securities Act of 1933, as amended.  The Company agrees that the Shares or, if the Shares are convertible into common stock of the Company, such common stock, shall be subject to the registration rights set forth on Exhibit B.

ARTICLE 4
MISCELLANEOUS

4.1           Term; Exercise Upon Expiration.  This Warrant is exercisable in whole or in part, at any time and from time to time on or after Octobers 1, 2006 if the Sale (as defined in the Credit Agreement dated as of March 31, 2004 between Nexsan Technologies Incorporated and Comerica Bank, as amended) has not been consummated (“Issue Date”).  This Warrant expires on the seventh anniversary of the Issue Date; provided, however, that if the Company completes its initial public offering within the one-year period immediately prior to the Expiration Date, the Expiration Date shall automatically be extended until the first anniversary of the effective date of the Company’s initial public offering.  The Company shall give Holder written notice of Holder’s right to exercise this Warrant not less than 90 days before the Expiration Date.  If the notice is not so given, the Expiration Date shall automatically be extended until 90 days after the date the Company delivers such notice to Holder.

4

4.2           Legends.  This Warrant and the Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) shall be imprinted with a legend in substantially the following form;

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO RULE 144 OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

4.3           Compliance with Securities Laws on Transfer.  This Warrant and the Shares issuable upon exercise of this Warrant (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part without compliance with applicable federal and state securities laws by the transferor and the transferee.

4.4           Transfer Procedure.  Subject to the provisions of Section 4.3, Holder may transfer all or part of this Warrant or the Shares issuable upon exercise of this Warrant (or the securities issuable, directly or indirectly, upon conversion of the Shares, if any) by giving the Company notice of the portion of this Warrant being transferred setting forth the name, address and taxpayer identification number of the transferee and surrendering this Warrant to the Company for reissuance to the transferee(s) (and Holder, if applicable); provided, however, that Holder may transfer all or part of this Warrant to its affiliates, including, without limitation, Comerica Incorporated, at any time without notice or the delivery of any other instrument to the Company, and such affiliate shall then be entitled to all the rights of Holder under this Warrant and any related agreements, and the Company shall cooperate fully in ensuring that any stock issued upon exercise of this Warrant is issued in the name of the affiliate that exercises this Warrant.  The terms and conditions of this Warrant shall inure to the benefit of, and be binding upon, the Company and the holders hereof and their respective permitted successors and assigns.  Unless the Company is filing financial information with the SEC pursuant to the Securities Exchange Act of 1934, the Company shall have the right to refuse to transfer any portion of this Warrant to any person who directly competes with the Company.

4.5           Notices.  All notices and other communications from the Company to the Holder, or vice versa, shall be deemed delivered and effective when given personally or mailed by first-class registered or certified mail, postage prepaid, at such address as may have been furnished to the Company or the Holder, as the case may be, in writing by the Company or such Holder from time to time.  All notices to the Holder shall be addressed as follows:

Comerica Bank c/o Comerica Incorporated

Attn: Warrant Administrator

500 Woodward Avenue, 32nd Floor, MC 3379

Detroit, MI 48226

5

All notices to the Company shall be addressed as follows:

Nexsan Corporation

21700 Oxnard Street, Suite 1850

Woodland Hills, CA 91367

4.6           Amendments.  This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought.

4.7           Attorneys’ Fees.  In the event of any dispute between the parties concerning the terms and provisions of this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys’ fees.

4.8           Governing Law.  This Warrant shall be governed by and construed in accordance with the laws of the State of California, without giving effect to its principles regarding conflicts of law.

4.9           Confidentiality.  The Company hereby agrees to keep the terms and conditions of this Warrant confidential.  Notwithstanding the foregoing confidentiality obligation, the Company may disclose information relating to this Warrant as required by law, rule, regulation, court order or other legal authority, provided that (i) the Company has given Holder at least ten (10) days’ notice of such required disclosure, and (ii) the Company only discloses information that is required, in the opinion of counsel reasonably satisfactory to Holder, to be disclosed.

[Remainder of Page Intentionally Left Blank]

6

7

APPENDIX 1

NOTICE OF EXERCISE

1.             The undersigned hereby elects to purchase                         shares of the                        stock of NEXSAN CORPORATION pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price of such shares in full.

2.             Please issue a certificate or certificates representing said shares in the name of the undersigned or in such other name as is specified below:

Comerica Bank

Attn: Warrant Administrator

500 Woodward Avenue, 32nd Floor, MC 3379

Detroit, MI 48226

3.             The undersigned represents it is acquiring the shares solely for its own account and not as a nominee for any other party and not with a view toward the resale or distribution thereof except in compliance with applicable securities laws.

COMERICA BANK or Assignee

EXHIBIT A

Anti-Dilution Provisions

In the event of the issuance (a “Diluting Issuance”) by the Company, after the Issue Date of this Warrant, of securities at a price per share less than the Warrant Price, then the number of shares of common stock issuable upon conversion of the Shares shall be adjusted in accordance with those provisions (the “Provisions”) of the Company’s Certificate of Incorporation which apply to Diluting Issuances The Provisions shall not be deemed in any manner to limit or restrict the applicability of the Provisions to the Shares.  Any language in the Provisions that in any manner limits or restricts the applicability of the Provisions to the Shares shall not apply to this Warrant.

Under no circumstances shall the aggregate Warrant Price payable by the Holder upon exercise of the Warrant increase as a result of any adjustment arising from a Diluting Issuance.

EXHIBIT B

Registration Rights

The Shares (if common stock), or the common stock issuable upon conversion of the Shares, shall be deemed “Series A Preferred Registrable Shares” for purposes of and entitle to “piggy back” registration rights in accordance with the terms of the following agreement (the “Agreement”) between the Company and its investor(s):

Second Amended and Restated Registration Rights Agreement dated October 27, 2003

The Company agrees that no amendments will be made to the Agreement, which would have an adverse impact on Holder’s registration rights thereunder without the consent of Holder, which consent shall not be unreasonably withheld.  By acceptance of the Warrant to which this Exhibit B is attached, Holder shall be deemed to be a party to the Agreement solely for the purpose of the above-mentioned registration rights.

If no Agreement exists, then the Company and the Holder shall enter into Holder’s standard form of Registration Rights Agreement as in effect on the Issue Date of the Warrant.

NEXSAN CORPORATION

March 21, 2008

Comerica Incorporated
Attn: Warrant Administrator
500 Woodward Avenue, 32^nd Floor
Detroit, Michigan 48226

Dear Warrant Administrator:

Reference is made to the following warrants initially issued to Comerica Bank by Nexsan Corporation, a Delaware corporation (“Nexsan”): (i) a Warrant issued on April 22, 2005 for the purchase of 50,000 shares of Series A Preferred Stock of Nexsan (the “April Warrant”); and (ii) a Warrant issued on October 1, 2006 for the purchase of 48,872 shares of Series A Preferred Stock of Nexsan (“October Warrant” together with the April Warrant, collectively, the “Warrants”). The Warrants were subsequently assigned by Comerica Bank to Comerica Incorporated.

As you have been previously informed, Nexsan is contemplating an initial public offering of its common stock (“IPO”) and intends to file a registration statement with the U.S. Securities and Exchange Commission (“SEC”). The proposed IPO has not yet been publicly announced and Nexsan is currently in what the SEC refers to as the “quiet period.” Any publicity about our planned IPO could jeopardize the IPO’s timing and success. Therefore, please treat this information as confidential.

In connection with the proposed IPO, and as an inducement for Nexsan and the representatives of the investment banks that are underwriting the IPO to continue their efforts in connection with the proposed IPO, the underwriters are requesting that you, as holder of the Warrants, acknowledge and confirm your consent to the following matters (collectively, the “Transactions”), which (except item 3 below) were effected in connection with (i) the issuance and sale of Series C Preferred Stock of Nexsan in March 2007 and (ii) the issuance of Common Stock of Nexsan and exchangeable shares of one of Nexsan’s Canadian subsidiaries in November 2007:

1.   The amendment and restatement of the certificate of incorporation of Nexsan which was filed with Delaware on March 29, 2007 as the Fifth Amended and Restated Certificate of Incorporation, as amended by the Amendment to the Fifth Amended and Restated Certificate of Incorporation filed on November 26, 2007 with Delaware (copies of the foregoing documents are attached hereto as Exhibit A (as amended, the “Certificate of Incorporation”));

2.     The amendment and restatement of the Second Amended and Restated Registration Rights Agreement, dated October 27, 2003, which was entered into as the Third Amended and Restated Registration Rights Agreement, dated March 29, 2007, as amended by the Amendment to the Third Amended and Restated Registration Rights

Agreement dated November 14, 2007 (copies of the foregoing documents are attached hereto as Exhibit B); and

3.     The matters described in the Written Consent and Waiver of the Stockholders of Nexsan which the stockholders of Nexsan have approved, a copy of which is attached hereto as Exhibit C, which includes a further amendment to the Third Amended and Restated Registration Rights Agreement dated March 29, 2007, as amended.

Further, the underwriters are requesting that you, as the holder of the Warrants, agree to the automatic termination of Section 2.4 (Adjustments for Diluting Issuances) of each of the Warrants upon consummation of the IPO.

Lastly, at the request of the underwriters, in order to eliminate ambiguity and conform the definitions in the Warrants to those in the Certificate of Incorporation, please confirm that from and after March 29, 2007 (the filing of the Certificate of Incorporation (as defined above) the following shall apply to the Warrants (referred to herein as “Definition Amendment”):

1.     The term “Conversion Price” as used in Exhibit A to the April Warrant means the “Series A Conversion Price” as defined in the Certificate of Incorporation (as defined above) and any adjustment pursuant to Section 2.4 (Adjustments for Diluting Issuances) of the April Warrant shall be applied to the April Warrant in the same manner and extent as applied to the Series A Preferred Stock under Section 4.3.5.4 of the Certificate of Incorporation;

2.     The term “Provisions” as used in Exhibit A to the October Warrant means those provisions of the Certificate of Incorporation which apply to the adjustment of the Series A Conversion Price, and any adjustment pursuant to Section 2.4 (Adjustments for Diluting Issuances) of the October Warrant shall be applied to the October Warrant in the same manner and extent as applied to the Series A Preferred Stock under Section 4.3.5.4 of the Certificate of Incorporation;

3.     Under the Certificate of Incorporation, the shares of common stock issuable upon conversion of the Series C Preferred Stock or pursuant to Section 3.6 of the Series C Purchase Agreement referred to therein are deemed “Series A Excluded Stock.” Accordingly, the issuance and sale of the Series C Preferred Stock of Nexsan in March, 2007 shall be deemed “Series A Excluded Stock” for purposes of the Warrants;

4.     By letter agreement among certain stockholders of Nexsan, the shares of Series A Preferred Stock or other equity securities of Nexsan (the “Terrapin Conversion Securities”) issuable upon conversion of that certain 8% Secured Subordinated Convertible Promissory Note, dated November 2, 2006 (the “Terrapin Note”), issued by Nexsan in favor of Terrapin Partners Nexsan Partnership LP constitute Series A Excluded Stock and Series C Excluded Stock under the Certificate of Incorporation. Accordingly, for all purposes of the Warrants, the Terrapin Note and the Terrapin Conversion Securities shall be deemed “Series A Excluded Stock”; and

2

5.     For all purposes of the Warrants, the sale and issuance of Common Stock of Nexsan by Nexsan in the IPO shall be deemed “Series A Excluded Stock.”

Please acknowledge and confirm your consent to the Transactions, Definition Amendment and the automatic termination of Section 2.4 (Adjustments for Diluting Issuances) of each of the Warrants upon consummation of the IPO (the “Termination of Section 2.4”) by signing and dating the enclosed copy of this letter in the space provided below and returning the copy to the undersigned; provided that, except for the Termination of Section 2.4, such acknowledgement and confirmation shall not constitute the waiver of any of your rights under the Warrants.

If you have any questions, please feel free to contact me.

3